Merck said it is recalling its combination cholesterol drug Liptruzet, which was introduced in May, because of packaging defects that could reduce effectiveness.
In a statement on its website, Whitehouse Station-based Merck said the recall will clear out the entire stock of Liptruzet, which includes all four dose strengths and every batch it has distributed.
Click here to read more.